TQ Quiz | AMD: The Past, Present, and Future (Phoenix 2023) by Events@optometricedu.com | Apr 17, 2023 | 2023 Phoenix, TQ Courses | 0 comments "*" indicates required fields HiddenAMD: The Past, Present, and FutureHiddenDate (Hidden) MM slash DD slash YYYY HiddenEvent Date (Hidden) MM slash DD slash YYYY HiddenEvent 60 days past date (Hidden) MM slash DD slash YYYY HiddenEvent Date Difference (Hidden)1. Previous treatment for AMD includes all of the following EXCEPT:* A - Macular photocoagulation B - Photodynamic therapy C - Rheophoresis D - Photobiomodulation 2. Which of the following was NOT recommended following the AREDS 2 study?* A - Lutein B - Zeaxanthin C - Zinc D - Omega 3 3. The AREDS 2 ten years study revealed* A - Results were sustained through 10 years B - Results lessened as time progressed C - Omega 3 was shown protective D - Continued vitamin use was shown unsafe 4. Which of the following statements regarding lifestyle and AMD is FALSE?* A - Smoking is the number one modifiable risk factor for AMD B - Most Americans live a very healthy lifestyle C - Adherence to a Mediterranean diet decreased progression to advanced AMD D - Even moderate exercise has been linked with reduced rates of AMD 5. Which of the following statement regarding Macugen is TRUE?* A - Is injected on a as needed basis B - Works better than Lucentis or Avastin C - Is the latest FDA approved drug for WET AMD D - Has been supplanted by Lucentis, Avastin and Eylea 6. Which of the following statements regarding Lucentis is TRUE?* A - 94% of patients treated had stable or improved vision B - 2/3 of patients treated had improved vision of 15 letters or more C - Initial studies recommend treatment every 2 weeks D - The cost is roughly $50 per injection 7. Which of the following statements regarding Avastin is TRUE?* A - It is FDA approved for the treatment of Wet AMD B - It is too large to penetrate into the retina C - It is the parent drug of Lucentis, and therefore closely related to it D - It is the most expensive of all the treatment options 8. Which of the following statements about Faricimab (Vabysmo, Genentech) is FALSE?* A - It is the first biphasic antibody for intraocular use B - Dual inhibition of VEGF and Ang 2 have proven more effective than inhibiting either target alone C - It is not injected intravitreally but rather administered orally D - Appears to be able to be injected less frequently than other options, perhaps every 16 weeks, following a loading dose 9. Which anti VEGF agent has fallen out of favor due to higher than expected rates of inflammation and retinal artery occlusion?* A - Susvima B - Vabysmo C - Byooviz D - Beovu 10. Which of the foll10. Which of the following is a port delivery system designed to give a steady supply of ranibizumab over 6 to 12 months?owing medications will interact with medications that increase serotonin levels?* A - Susvima B - Vabysmo C - Byooviz D - Beovu 11. Which of the following is a commercially available instrument that can measure a patients dark adaptation?* A - MacuScope B - MaculaRisk C - AdaptDX D - RetnaGene 12. Which of the following statements regarding dark adaptation is FALSE?* A - Impaired dark adaptation my precede the clinical findings of AMD by 3 years B - Dark adaptation diminishes with age, so is not a useful marker for AMD C - Dark adaptation may provide a useful tool to monitor for worsening AMD D - Allows functional testing of AMD, similar to visual field testing in glaucoma 13. With OCT-Angiography, which of the following layers of the retina is AVASCULAR and thus should not have any vessels, unless there is an underlying disease process such as CNVM?* A - Superficial capillary plexus B - Deep capillary plexus C - Outer retinal zone D - Choriocapillaris 14. In regards to AMD, OCTA may be useful for the following EXCEPT* A - Locate small CNVMs as soon as possible to get prompt treatment B - Differentiate from similar conditions that my look the same C - Track changes in size to see if therapy is working D - Predict a patients response to therapy 15. According to the HOME study* A - Only 5% more patients retained 20/40 or better vision when using home monitoring versus standard protocol B - 50% more patients retained 20/40 or better when using home monitoring versus standard protocol C - The same percentage of patients retained 20/40 vision or better in both groups D - The standard protocol group experienced better vision overall 16. What percentage of attributable risk for AMD is associated with genetics?* A - 10% B - 30% C - 70% D - 100% 17. Researchers feel the single most important genetic marker for AMD is* A - Complement factor H B - Complement factor 3 C - BRACA D - TIMP3 18. Risk factors for AMD include all of the flowing EXCEPT:* A - Age B - Smoking C - Increased BMI D - Refractive error 19. Knowledge of genetic risk* A - May lead to increased counseling for high risk patients B - May indicate which patients need to be flowed more closely C - May have implications regarding treatment D - All of the above 20. All of the following are in studies for treatment of geographic atrophy EXCEPT* A - Pegcetoplan by Apellis B - GT1005 by Gyroscope Therapeutics C - Oracea, low dose doxycycline D - Lamipizumab, by Genentech Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional Code AMD: The Past, Present, and Future | TQ Credit*After 5/5/2023, pricing will increase to $30. Price: (Past 60 Days) AMD: The Past, Present, and Future | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Paying Via Credit Card A Paypal account is not required to pay using the button below. To pay using a credit card, click the Paypal button below. A new window will appear and a button "Pay with Debit or Credit Card" is available at the bottom of that window for your convenience. Payment MethodPayPal Checkout MasterCardVisaSupported Credit Cards: MasterCard, Visa Card Number Expiration Date Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
